Summary of key demographic and health factors present in the MACS data, based on the prescribed treatment at visits 1 and 2.
| Visit 1 . | No AZT . | AZT prescribed . | |
|---|---|---|---|
| Visit 2 . | No AZT . | AZT prescribed . | AZT prescribed . |
| (N = 2614) | (N = 90) | (N = 57) | |
| Age (years in 1986) | |||
| Mean (SD) | 35.6 (8.22) | 36.3 (7.53) | 31.6 (8.79) |
| Median [min, max] | 35.0 [-2.00, 72.0] | 35.0 [19.0, 58.0] | 33.0 [15.0, 50.0] |
| CD4 count (visit 1) | |||
| Mean (SD) | 891 (408) | 329 (236) | 341 (248) |
| Median [min, max] | 864 [9.00, 2800] | 267 [13.0, 929] | 297 [18.0, 993] |
| CD4 count (visit 2) | |||
| Mean (SD) | 849 (409) | 331 (230) | 316 (253) |
| Median [min, max] | 823 [6.00, 2640] | 297 [8.00, 936] | 291 [9.00, 1070] |
| Body weight (lbs) (visit 1) | |||
| Mean (SD) | 171 (28.7) | 167 (26.1) | 171 (45.7) |
| Median [min, max] | 166 [56.4, 408] | 163 [125, 270] | 165 [116, 442] |
| Body weight (lbs) (visit 2) | |||
| Mean (SD) | 172 (30.1) | 169 (27.7) | 166 (39.5) |
| Median [min, max] | 168 [47.4, 409] | 163 [125, 288] | 164 [49.6, 348] |
| Symptoms present (visit 1) | |||
| No symptoms | 2519 (96.4%) | 74 (82.2%) | 36 (63.2%) |
| Symptoms | 95 (3.6%) | 16 (17.8%) | 21 (36.8%) |
| Symptoms present (visit 2) | |||
| No symptoms | 2502 (95.7%) | 69 (76.7%) | 45 (78.9%) |
| Symptoms | 112 (4.3%) | 21 (23.3%) | 12 (21.1%) |
| Visit 1 . | No AZT . | AZT prescribed . | |
|---|---|---|---|
| Visit 2 . | No AZT . | AZT prescribed . | AZT prescribed . |
| (N = 2614) | (N = 90) | (N = 57) | |
| Age (years in 1986) | |||
| Mean (SD) | 35.6 (8.22) | 36.3 (7.53) | 31.6 (8.79) |
| Median [min, max] | 35.0 [-2.00, 72.0] | 35.0 [19.0, 58.0] | 33.0 [15.0, 50.0] |
| CD4 count (visit 1) | |||
| Mean (SD) | 891 (408) | 329 (236) | 341 (248) |
| Median [min, max] | 864 [9.00, 2800] | 267 [13.0, 929] | 297 [18.0, 993] |
| CD4 count (visit 2) | |||
| Mean (SD) | 849 (409) | 331 (230) | 316 (253) |
| Median [min, max] | 823 [6.00, 2640] | 297 [8.00, 936] | 291 [9.00, 1070] |
| Body weight (lbs) (visit 1) | |||
| Mean (SD) | 171 (28.7) | 167 (26.1) | 171 (45.7) |
| Median [min, max] | 166 [56.4, 408] | 163 [125, 270] | 165 [116, 442] |
| Body weight (lbs) (visit 2) | |||
| Mean (SD) | 172 (30.1) | 169 (27.7) | 166 (39.5) |
| Median [min, max] | 168 [47.4, 409] | 163 [125, 288] | 164 [49.6, 348] |
| Symptoms present (visit 1) | |||
| No symptoms | 2519 (96.4%) | 74 (82.2%) | 36 (63.2%) |
| Symptoms | 95 (3.6%) | 16 (17.8%) | 21 (36.8%) |
| Symptoms present (visit 2) | |||
| No symptoms | 2502 (95.7%) | 69 (76.7%) | 45 (78.9%) |
| Symptoms | 112 (4.3%) | 21 (23.3%) | 12 (21.1%) |
All individuals prescribed AZT at visit 1 (N = 57) will remain on AZT at visit 2.
Summary of key demographic and health factors present in the MACS data, based on the prescribed treatment at visits 1 and 2.
| Visit 1 . | No AZT . | AZT prescribed . | |
|---|---|---|---|
| Visit 2 . | No AZT . | AZT prescribed . | AZT prescribed . |
| (N = 2614) | (N = 90) | (N = 57) | |
| Age (years in 1986) | |||
| Mean (SD) | 35.6 (8.22) | 36.3 (7.53) | 31.6 (8.79) |
| Median [min, max] | 35.0 [-2.00, 72.0] | 35.0 [19.0, 58.0] | 33.0 [15.0, 50.0] |
| CD4 count (visit 1) | |||
| Mean (SD) | 891 (408) | 329 (236) | 341 (248) |
| Median [min, max] | 864 [9.00, 2800] | 267 [13.0, 929] | 297 [18.0, 993] |
| CD4 count (visit 2) | |||
| Mean (SD) | 849 (409) | 331 (230) | 316 (253) |
| Median [min, max] | 823 [6.00, 2640] | 297 [8.00, 936] | 291 [9.00, 1070] |
| Body weight (lbs) (visit 1) | |||
| Mean (SD) | 171 (28.7) | 167 (26.1) | 171 (45.7) |
| Median [min, max] | 166 [56.4, 408] | 163 [125, 270] | 165 [116, 442] |
| Body weight (lbs) (visit 2) | |||
| Mean (SD) | 172 (30.1) | 169 (27.7) | 166 (39.5) |
| Median [min, max] | 168 [47.4, 409] | 163 [125, 288] | 164 [49.6, 348] |
| Symptoms present (visit 1) | |||
| No symptoms | 2519 (96.4%) | 74 (82.2%) | 36 (63.2%) |
| Symptoms | 95 (3.6%) | 16 (17.8%) | 21 (36.8%) |
| Symptoms present (visit 2) | |||
| No symptoms | 2502 (95.7%) | 69 (76.7%) | 45 (78.9%) |
| Symptoms | 112 (4.3%) | 21 (23.3%) | 12 (21.1%) |
| Visit 1 . | No AZT . | AZT prescribed . | |
|---|---|---|---|
| Visit 2 . | No AZT . | AZT prescribed . | AZT prescribed . |
| (N = 2614) | (N = 90) | (N = 57) | |
| Age (years in 1986) | |||
| Mean (SD) | 35.6 (8.22) | 36.3 (7.53) | 31.6 (8.79) |
| Median [min, max] | 35.0 [-2.00, 72.0] | 35.0 [19.0, 58.0] | 33.0 [15.0, 50.0] |
| CD4 count (visit 1) | |||
| Mean (SD) | 891 (408) | 329 (236) | 341 (248) |
| Median [min, max] | 864 [9.00, 2800] | 267 [13.0, 929] | 297 [18.0, 993] |
| CD4 count (visit 2) | |||
| Mean (SD) | 849 (409) | 331 (230) | 316 (253) |
| Median [min, max] | 823 [6.00, 2640] | 297 [8.00, 936] | 291 [9.00, 1070] |
| Body weight (lbs) (visit 1) | |||
| Mean (SD) | 171 (28.7) | 167 (26.1) | 171 (45.7) |
| Median [min, max] | 166 [56.4, 408] | 163 [125, 270] | 165 [116, 442] |
| Body weight (lbs) (visit 2) | |||
| Mean (SD) | 172 (30.1) | 169 (27.7) | 166 (39.5) |
| Median [min, max] | 168 [47.4, 409] | 163 [125, 288] | 164 [49.6, 348] |
| Symptoms present (visit 1) | |||
| No symptoms | 2519 (96.4%) | 74 (82.2%) | 36 (63.2%) |
| Symptoms | 95 (3.6%) | 16 (17.8%) | 21 (36.8%) |
| Symptoms present (visit 2) | |||
| No symptoms | 2502 (95.7%) | 69 (76.7%) | 45 (78.9%) |
| Symptoms | 112 (4.3%) | 21 (23.3%) | 12 (21.1%) |
All individuals prescribed AZT at visit 1 (N = 57) will remain on AZT at visit 2.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
